Nina Stachenfeld

No ORCID on file · 3 papers in corpus
article 2026
Microvascular endothelial function is preserved during short-term estrogen suppression with Elagolix® in women with endometriosis
·doi:10.1152/physiol.2026.41.s1.2294842

Cardiovascular disease (CVD) risk is elevated in women with endometriosis (ENDO). Because estrogen is cardioprotective in some women, this CVD risk might be exacerbated by common ENDO treatments that suppress estrogen. The purpose of this s…

article 2022
Endometriosis promotes atherosclerosis in a murine model
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2022.03.040

BackgroundEpidemiologic studies have demonstrated an association between endometriosis and the subsequent development of cardiovascular disease. The direct effect of endometriosis on the progression of atherosclerotic, if any, has not been …

article 2022
Seven days of statin treatment improves nitric-oxide mediated endothelial-dependent cutaneous microvascular function in women with endometriosis
Microvascular research ·doi:10.1016/j.mvr.2022.104421

INTRODUCTION: Endometriosis is associated with systemic inflammation and increased risk of cardiovascular disease (CVD). Endothelial dysfunction is one of the first manifestations of CVD but is unexplored in women with endometriosis. HMG-Co…